Bristol-Myers Squibb Company Financial Ratios — BRM Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	23.42	13.25	17.81	13.36	10.75	29.28	7.21	38.18	10.48	-20.16	18.96	18.88	26.53	-39.1	40.53
Return on Assets (%)	11.58	5.69	6.88	5.54	4.78	13.62	2.99	14.36	4.17	-7.26	6.14	6.14	8.36	-9.53	7.72
Return on Capital (%)	10.68	- -	12.21	9.28	7.48	20.53	5.02	24.44	6.42	- -	9.5	9.54	12.78	- -	12.73
Return on Invested Capital (%)	23.22	- -	10.71	7.38	5.13	16.89	3.28	20.22	3.99	- -	6.92	8.07	9.32	- -	9.67
Gross Margin (%)	73.65	73.84	71.81	75.24	76.39	74.42	71.05	71.34	69.1	72.31	78.57	78.04	76.24	71.08	71.08
EBITDA Margin (%)	33.8	15.15	21.06	15.65	11.06	27.42	21.59	25.2	20.04	4.4	37.77	38.6	37.31	2.2	25.96
Operating Margin (%)	31.24	22.31	17.89	10.79	10.45	23.36	16.59	22.79	16.5	5.15	18.4	19.72	18.21	12.19	28.48
Incremental Operating Margin (%)	39.03	74.66	80.99	240.51	2.35	97.98	- -	94.9	- -	- -	164.13	- -	78.84	- -	- -
Pretax Margin (%)	32.86	13.28	17.64	14.99	12.54	30.45	24.7	26.45	19.03	-16.16	17.46	16.71	18.75	-17.35	19.35
Profit Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Net Income to Common Margin (%)	17.46	11.12	15.64	12.62	9.45	22.94	4.85	21.81	13.15	-21.2	15.08	13.71	17.83	-18.53	14.64
Effective Tax Rate (%)	24.65	- -	10.76	14.78	21.47	23.8	81	17.11	30.45	- -	13.39	17.74	4.74	- -	24.36
Dvd Payout Ratio (%)	33.09	75.15	88.91	116.75	145.96	55.89	273.28	52.53	76.96	-45.4	62.5	72.83	58.9	-54.53	71.49
Sustainable Growth Rate (%)	15.67	3.29	1.98	-2.24	-4.94	12.92	-12.5	18.12	2.41	-29.32	7.11	5.13	10.91	-60.43	11.56

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
ST Debt	115	826	359	590	139	992	987	1,703	3,479	2,504	5,117	4,400	3,281	2,227	2,463
LT Debt	5,376	6,568	7,981	7,242	6,550	5,716	6,975	5,646	44,059	49,169	40,479	36,317	38,183	48,973	44,676
Total Debt/EBITDA	0.76	2.77	2.42	3.15	3.65	1.26	1.78	1.29	9.07	27.63	2.6	2.29	2.47	48.26	3.77
Net Debt/EBITDA	-0.04	2.15	1.38	0.91	2.35	0.46	0.57	0.08	6.56	19.32	1.75	1.69	1.69	37.04	2.79
Total Debt/EBIT	0.84	3.72	3.1	3.88	4.59	1.36	2.15	1.46	13.61	-6.07	6.67	5.4	5.9	-6	5.55
Net Debt/EBIT	-0.04	2.89	1.77	1.12	2.96	0.5	0.69	0.09	9.84	-4.25	4.47	4	4.03	-4.6	4.11
EBITDA to Interest Expense	49.52	14.66	17.34	12.24	9.96	31.89	22.88	31.07	7.99	1.32	13.13	14.46	14.4	0.54	6.62
EBITDA-CapEx/Interest Expense	46.99	11.65	14.64	9.65	9.96	31.89	22.88	31.07	7.99	1.32	13.13	14.46	14.4	0.54	6.62
EBIT to Interest Expense	45.77	21.6	14.73	8.44	9.4	27.18	17.59	28.09	6.58	1.54	6.4	7.39	7.03	3.02	7.26
Interest Expense	145	182	199	203	184	167	196	183	656	1,420	1,334	1,232	1,166	1,947	1,891
Common Equity/Total Assets	48.4	37.95	39.27	44.01	44.94	47.99	34.99	40.1	39.71	31.92	32.88	32.08	30.93	17.64	20.52
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	25.17	31.23	33.85	31.74	31.02	24.79	35.21	26.29	44.4	54.9	49.61	50.56	53.82	72.46	68.06
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	25.71	35.16	35.37	34.33	31.68	29.1	40.19	34.22	47.9	57.7	55.88	56.68	58.44	75.75	71.81
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
Net Debt to Equity	-1.8	42.07	31.2	15.09	29.84	15.12	21.45	3.1	66.52	95.38	84.91	97.04	96.01	239.83	188.6
Net Debt/Capital (%)	-1.83	29.61	23.78	13.11	22.98	13.13	17.66	3.01	39.58	48.17	45.21	48.15	47.59	68.66	62.96
EBITDA	7,180	2,669	3,450	2,485	1,832	5,326	4,485	5,685	5,240	1,870	17,519	17,817	16,793	1,061	12,510
EBITDA-CapEx	6,813	2,121	2,913	1,959	1,832	5,326	4,485	5,685	5,240	1,870	17,519	17,817	16,793	1,061	12,510
Operating Income (Loss)	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.12	0.34	0.36	0.88	0.53	0.72	0.71	0.82	0.84	0.86	0.79	0.42	0.55	0.46	0.46
Current Ratio	1.97	1.15	1.52	1.73	1.3	1.55	1.55	1.66	1.6	1.58	1.52	1.25	1.43	1.25	1.26
Quick Ratio	1.6	0.71	0.63	1.28	1.07	1.35	1.37	1.36	1.26	1.42	1.36	1.06	1.24	1.06	1.08
CFO/Avg Current Liab	0.67	0.86	0.34	0.3	0.26	0.36	0.57	0.7	0.57	0.75	0.79	0.6	0.63	0.66	0.6
Common Equity/Total Assets	48.4	37.95	39.27	44.01	44.94	47.99	34.99	40.1	39.71	31.92	32.88	32.08	30.93	17.64	20.52
Long-Term Debt/Equity (%)	33.88	48.16	52.38	48.33	45.41	34.97	58.88	39.97	85.22	129.8	112.42	116.71	129.5	298.83	241.41
Long-Term Debt/Capital (%)	25.17	31.23	33.85	31.74	31.02	24.79	35.21	26.29	44.4	54.9	49.61	50.56	53.82	72.46	68.06
Long-Term Debt/Total Assets (%)	16.31	18.3	20.68	21.46	20.63	16.96	20.79	16.14	33.91	41.5	37.03	37.51	40.13	52.88	49.62
Total Debt/Equity (%)	34.61	54.22	54.74	52.27	46.37	41.04	67.21	52.02	91.95	136.41	126.63	130.85	140.63	312.42	254.72
Total Debt/Capital (%)	25.71	35.16	35.37	34.33	31.68	29.1	40.19	34.22	47.9	57.7	55.88	56.68	58.44	75.75	71.81
Total Debt/Total Assets (%)	16.65	20.6	21.61	23.21	21.07	19.9	23.73	21.01	36.58	43.61	41.71	42.05	43.57	55.29	52.35
CFO/Total Liabilities	28.3	31.18	15.18	16.78	12.15	17.62	24.3	33.88	10.49	17.43	22.11	19.89	21.1	19.93	19.79
CFO/CapEx	13.19	12.67	6.6	5.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	6.16	5.43	5.02	6.16	7	6.81	5.99	5.86	3.45	3.11	3.74	4.37	3.61	2.94	3.46

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	8.9	9.64	8.38	6.56	5.78	5.12	5.02	4.71	6.21	6.1	5.72	5.28	5.4	5.18
Days Sales Outstanding	- -	40.99	37.85	43.56	55.63	63.15	71.34	72.67	77.57	58.78	59.8	63.77	69.07	67.61	70.45
Inventory Turnover	4.33	3.03	2.93	2.57	2.81	4.04	5	5.48	2.94	3.7	4.77	4.57	4.28	5.35	5.31
Days Inventory Outstanding	84.37	120.39	124.66	141.93	129.84	90.42	73.04	66.63	123.99	98.7	76.54	79.83	85.35	68.19	68.71
Accounts Payable Turnover	2.52	2.03	1.87	1.58	1.76	3.09	3.04	3.14	5.15	3.7	3.52	3.47	3.5	4.04	3.92
Accounts Payable Turnover Days	144.85	179.58	194.82	230.57	207.14	118.12	120.21	116.31	70.82	98.53	103.74	105.29	104.35	90.32	93.1
Cash Conversion Cycle	- -	-18.21	-32.31	-45.08	-21.67	35.45	24.17	22.98	130.73	58.95	32.6	38.31	50.07	45.48	46.06
Inventory to Cash Days	- -	-79.39	-86.81	-98.38	-74.21	-27.28	-1.71	6.04	-46.42	-39.92	-16.75	-16.05	-16.28	-0.58	1.74
Inventories	1,384	1,657	1,498	1,560	1,221	1,241	1,166	1,195	4,293	2,074	2,095	2,339	2,662	2,557	2,690
Raw Materials	260	271	250	204	199	264	273	116	172	207	350	464	- -	- -	- -
Work In Process	646	814	757	856	868	988	931	1,152	3,267	2,015	2,111	1,850	- -	- -	- -
Finished Goods	478	572	491	500	381	310	384	356	2,227	932	543	509	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,080	-909	-484	2,662	2,557	2,690

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	60,007	52,915	88,700	99,399	116,508	97,856	100,155	82,176	143,783	137,556	134,200	149,198	103,961	115,855	109,047
- Cash & Cash Equivalents	5,776	1,656	3,586	5,571	2,385	4,237	5,421	6,911	12,346	14,546	13,979	9,123	11,464	10,346	10,209
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	-89	15	82	131	158	170	106	96	100	60	60	57	55	53	33
+ Total Debt	5,491	7,394	8,340	7,832	6,689	6,708	7,962	7,349	47,538	51,673	45,596	40,717	41,464	51,200	47,139
Enterprise Value	56,676	57,495	92,597	99,927	119,085	98,384	101,411	80,862	176,028	172,839	162,635	180,719	133,200	156,249	145,546
Total Capital	21,358	21,032	23,576	22,815	21,113	23,055	19,809	21,476	99,236	89,555	81,602	71,835	70,949	67,588	65,645
Total Debt/Capital (%)	25.71	35.16	35.37	34.33	31.68	29.1	40.19	34.22	47.9	57.7	55.88	56.68	58.44	75.75	71.81
Total Debt / EV	0.1	0.13	0.09	0.08	0.06	0.07	0.08	0.09	0.27	0.3	0.28	0.23	0.31	0.33	0.32
EV/Sales	2.67	3.26	5.65	6.29	7.19	5.06	4.88	3.58	6.73	4.07	3.51	3.92	2.96	3.23	3.02
EV/EBITDA	7.89	21.54	26.84	40.21	65	18.47	22.61	14.22	33.59	92.43	9.28	10.14	7.93	147.27	11.63
EV/EBIT	8.65	28.92	34.46	49.52	81.79	19.9	27.44	16.02	50.38	- -	23.8	23.96	18.94	- -	17.13
EV/Cash Flow to Firm	11.45	- -	24.87	30.09	52.94	30.89	19.09	11.2	20.31	- -	9.37	12.84	8.9	- -	9.34
EV/Free Cash Flow to Firm	12.37	- -	29.07	35.75	52.94	30.89	19.09	11.2	20.31	- -	9.37	12.84	8.9	- -	9.34
Diluted Market Cap	61,146	54,798	89,835	100,421	117,771	98,797	101,819	82,834	110,483	139,847	139,934	154,303	106,893	115,741	109,221
Diluted Enterprise Value	57,815	59,378	93,732	100,949	120,348	99,325	103,075	81,520	142,728	175,130	168,369	185,824	136,132	156,135	145,720
EV per Share	33.64	35.27	56.43	60.45	71.69	59.13	62.41	49.79	79.01	77.82	75.54	87.09	65.91	77.01	71.49
TTM Sales	21,244	17,621	16,385	15,879	16,560	19,427	20,776	22,561	26,145	42,518	46,385	46,159	45,006	48,300	48,195
TTM EBITDA	7,180	2,669	3,450	2,485	1,832	5,326	4,485	5,685	5,240	1,870	17,519	17,817	16,793	1,061	12,510
TTM Operating Income	6,637	3,932	2,931	1,714	1,730	4,539	3,447	5,141	4,314	2,190	8,537	9,104	8,195	5,887	13,724
TTM Cash Flow to Firm	4,949	- -	3,723	3,321	2,249	3,185	5,312	7,218	8,666	- -	17,362	14,079	14,971	- -	15,586
TTM Free Cash Flow to Firm	4,582	- -	3,186	2,795	2,249	3,185	5,312	7,218	8,666	- -	17,362	14,079	14,971	- -	15,586

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	13.67	8.57	29.87	38.3	55.95	32.31	19.3	11.72	13.46	9.95	8.63	11.81	7.71	7.62	7.72
EV/EBIT	8.65	28.92	34.46	49.52	81.79	19.9	27.44	16.02	50.38	- -	23.8	23.96	18.94	- -	17.13
Enterprise Value	56,676	57,495	92,597	99,927	119,085	98,384	101,411	80,862	176,028	172,839	162,635	180,719	133,200	156,249	145,546
Low Price	24.59	30.55	32.35	46.54	57.02	49	46.59	47.47	41.87	46.84	53.45	61.17	48.15	39.48	42.41
EV/Sales	2.67	3.26	5.65	6.29	7.19	5.06	4.88	3.58	6.73	4.07	3.51	3.92	2.96	3.23	3.02
EV/EBITDA	7.89	21.54	26.84	40.21	65	18.47	22.61	14.22	33.59	92.43	9.28	10.14	7.93	147.27	11.63
Price/Earnings	16.32	27.66	34.67	49.72	74.71	22.05	100.68	16.79	32	- -	19.19	24.21	13.26	- -	15.45
Price/Earnings Average	13.18	28.32	28.06	43.06	68.79	23.66	94	19.19	24.81	- -	19.4	24.49	16.19	- -	14.54
Price/Earnings High	16.34	31.01	34.98	51.7	75.98	28.99	107.3	23.12	32.03	- -	21.66	27.75	19.36	- -	18.19
Price/Earnings Low	11.27	26.03	20.75	38.48	60.73	18.37	76.11	15.76	20.76	- -	16.46	20.59	12.41	- -	12.23
Price/Book Value	3.76	3.88	5.85	6.69	8.17	6.05	8.53	5.86	2.79	3.64	3.73	4.8	3.53	7.09	5.9
Price/Book Value Average	3.04	3.98	4.74	5.8	7.52	6.49	7.96	6.69	2.16	3.57	3.78	4.86	4.31	6.15	5.56
Price/Book Value High	3.76	4.35	5.91	6.96	8.3	7.95	9.09	8.06	2.79	4	4.21	5.51	5.16	7.75	6.95
Price/Book Value Low	2.6	3.66	3.5	5.18	6.64	5.04	6.45	5.49	1.81	2.75	3.2	4.09	3.31	4.9	4.67
Price/Tangible Book Value	8.28	-18.97	15.45	16.37	19.53	12.36	27.31	12.84	-4.12	-3.8	-4.91	-5.64	-5.41	-3.99	-4.82
Price/Tangible Book Value Average	6.68	-19.42	12.51	14.18	17.98	13.26	25.49	14.67	-3.2	-3.73	-4.97	-5.71	-6.6	-3.46	-4.53
Price/Tangible Book Value High	8.29	-21.26	15.59	17.02	19.86	16.25	29.1	17.67	-4.13	-4.18	-5.54	-6.47	-7.89	-4.36	-5.67
Price/Tangible Book Value Low	5.72	-17.85	9.25	12.67	15.87	10.3	20.64	12.04	-2.68	-2.88	-4.21	-4.8	-5.06	-2.76	-3.81
Price/Sales	2.85	3.08	5.42	6.27	7.06	5.06	4.88	3.66	4.21	3.29	2.89	3.32	2.36	2.4	2.26
Price/Sales Average	2.3	3.15	4.39	5.43	6.5	5.43	4.56	4.18	3.26	3.23	2.93	3.36	2.89	2.08	2.13
Price/Sales High	2.85	3.45	5.47	6.52	7.18	6.65	5.2	5.04	4.21	3.61	3.27	3.8	3.45	2.62	2.66
Price/Sales Low	1.97	2.9	3.25	4.86	5.74	4.22	3.69	3.44	2.73	2.49	2.48	2.82	2.21	1.66	1.79
Price/Cash Flow	12.51	7.81	25.07	31.65	55.55	32.13	19.22	11.69	13.4	9.95	8.28	11.72	7.68	7.62	7.7
Price/Cash Flow Average	10.1	8	20.29	27.41	51.15	34.49	17.95	13.36	10.39	9.76	8.37	11.86	9.38	6.6	7.24
Price/Cash Flow High	12.52	8.76	25.29	32.91	56.49	42.26	20.48	16.1	13.42	10.94	9.35	13.44	11.21	8.32	9.07
Price/Cash Flow Low	8.64	7.35	15	24.5	45.15	26.78	14.53	10.97	8.69	7.53	7.1	9.97	7.19	5.27	6.09
Price/Free Cash Flow Average	11.03	8.78	24.17	33.17	51.51	34.67	18.02	13.39	10.44	9.76	8.73	11.95	9.42	6.6	7.26
Price/Free Cash Flow High	13.68	9.61	30.13	39.82	56.89	42.48	20.57	16.14	13.47	10.94	9.75	13.54	11.26	8.32	9.09
Price/Free Cash Flow Low	9.44	8.07	17.87	29.64	45.48	26.92	14.59	11	8.73	7.53	7.4	10.05	7.22	5.27	6.11
EV/Sales Average	2.12	3.33	4.62	5.45	6.63	5.43	4.56	4.1	5.5	4	3.54	3.95	3.47	2.92	2.89
EV/Sales High	2.67	3.63	5.7	6.54	7.31	6.65	5.2	4.96	6.74	4.39	3.88	4.39	4.02	3.46	3.42
EV/Sales Low	1.79	3.09	3.48	4.88	5.87	4.22	3.7	3.36	4.8	3.28	3.09	3.43	2.81	2.49	2.55
EV/EBITDA Average	6.28	22.02	21.94	34.85	59.96	19.82	21.13	16.28	27.43	91.02	9.37	10.24	9.3	132.7	11.12
EV/EBITDA High	7.9	23.94	27.07	41.8	66.08	24.26	24.08	19.67	33.63	99.7	10.27	11.37	10.78	157.32	13.18
EV/EBITDA Low	5.31	20.37	16.51	31.17	53.1	15.41	17.16	13.33	23.95	74.5	8.19	8.89	7.54	113.58	9.82
EV/EBIT Average	6.88	29.56	28.17	42.92	75.45	21.35	25.64	18.34	41.14	- -	24.02	24.19	22.21	- -	16.37
EV/EBIT High	8.66	32.14	34.75	51.47	83.14	26.13	29.22	22.15	50.43	- -	26.33	26.86	25.73	- -	19.41
EV/EBIT Low	5.81	27.35	21.2	38.39	66.82	16.6	20.82	15.01	35.93	- -	21	21.01	17.99	- -	14.45
Last Price	35.61	32.46	54.05	60.13	70.14	58.81	61.63	50.6	64.53	61.93	62.33	71.9	51.44	57.1	53.57
High Price	35.64	36.39	54.53	62.52	71.33	77.33	65.69	69.65	64.61	68.06	70.37	82.44	75.09	62.36	63.09
Enterprise Value Average	45,105	58,763	75,683	86,605	109,850	105,542	94,765	92,578	143,757	170,204	164,150	182,453	156,170	140,796	139,123
Enterprise Value High	56,730	63,903	93,382	103,876	121,056	129,203	107,994	111,805	176,196	186,446	179,937	202,577	180,987	166,917	164,936
Enterprise Value Low	38,099	54,380	56,976	77,462	97,283	82,070	76,968	75,783	125,523	139,319	143,522	158,443	126,541	120,508	122,844

Shares Outstanding	1,685	1,630	1,641	1,653	1,661	1,664	1,625	1,624	2,228	2,221	2,153	2,075	2,021	2,029	2,036
Diluted Weighted Avg Shares	1,717	1,688	1,662	1,670	1,679	1,680	1,652	1,637	1,712	2,258	2,245	2,146	2,078	2,027	2,039
Basic Weighted Avg Shares	1,700	1,670	1,644	1,657	1,667	1,671	1,645	1,633	1,705	2,258	2,153	2,130	2,069	2,027	2,034
Revenue per Share	12.5	10.55	9.97	9.58	9.93	11.63	12.63	13.82	15.33	18.83	21.54	21.67	21.75	23.83	23.69
EBITDA per Share	4.22	1.6	2.1	1.5	1.1	3.19	2.73	3.48	3.07	0.83	8.14	8.36	8.12	0.52	6.15
Operating Income per Share	3.9	2.35	1.78	1.03	1.04	2.72	2.1	3.15	2.53	0.97	3.97	4.27	3.96	2.9	6.75
Basic EPS, GAAP	2.18	1.17	1.56	1.21	0.94	2.67	0.61	3.01	2.02	-3.99	3.25	2.97	3.88	-4.41	3.47
Basic EPS from Cont Ops	3.09	1.5	1.57	1.22	0.98	2.7	0.59	3.03	2.03	-3.98	3.26	2.98	3.89	-4.41	3.47
Diluted EPS, GAAP	2.16	1.16	1.54	1.2	0.93	2.65	0.61	3.01	2.01	-3.99	3.12	2.95	3.86	-4.41	3.46
Diluted EPS from Cont Ops	3.06	1.48	1.55	1.21	0.97	2.68	0.59	3.02	2.02	-3.98	3.12	2.96	3.87	-4.41	3.46
Dividend per Share	1.33	1.37	1.4	1.45	1.49	1.52	1.57	1.6	1.57	1.8	2.04	2.18	2.29	2.4	2.48
Cash Flow per Share	2.85	4.16	2.16	1.9	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Free Cash Flow per Basic Share	2.63	3.83	1.83	1.58	1.26	1.83	3.21	4.33	4.82	6.22	7.53	6.13	6.7	7.49	6.96
Cash & Equivalents per Share	5.18	1.74	2.76	4.5	2.57	3.82	4.19	5.39	6.91	7.41	8	4.46	6.08	5.35	5.24
Book Value per Share	9.47	8.36	9.23	8.98	8.59	9.72	7.23	8.64	23.16	17.03	16.7	14.97	14.56	8.05	9.07
Tangible Book Value per Share	4.3	-1.71	3.5	3.67	3.59	4.76	2.26	3.94	-15.65	-16.29	-12.69	-12.74	-9.51	-14.31	-11.12

Bristol-Myers Squibb Company

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)